The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Pirfenidone Teva 267 mg film-coated tablets



Norton WaterfordPA0436/048/001

Main Information

Trade NamePirfenidone Teva 267 mg film-coated tablets
Active SubstancesPirfenidone
Dosage FormFilm-coated tablet
Licence HolderNorton Waterford
Licence NumberPA0436/048/001

Group Information

ATC CodeL04AX05 pirfenidone

Status

License statusAuthorised
Licence Issued24/06/2022
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Educational Materials - HCP

Generics Information

Interchangeable List CodeIC0127-173-009
Interchangeable List DocumentPDF of Interchangeable List
« Back